+36.1%
MRNA vs THC
+251.0%
-214.9%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.1% | +5.3% | +5.4% |
| 7D | -1.1% | -0.5% | -0.6% | -1.0% |
| 30D | +126.1% | -1.2% | +127.3% | +126.0% |
| 3M | +190.0% | +52.3% | +137.8% | +166.9% |
| 6M | +157.2% | +12.4% | +144.8% | +149.7% |
| YTD | +388.2% | +32.7% | +355.5% | +357.3% |
| 1Y | +467.0% | +36.4% | +430.7% | +426.2% |
| 3Y | +36.1% | +259.3% | -223.2% | -9.8% |
| All | +36.1% | +251.0% | -214.9% | -9.8% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling